What changed
The federal Department of Health, Disability and Ageing amended the rules that govern the prices and conditions under which the Commonwealth pays for Pharmaceutical Benefits Scheme (PBS) medicines. The amendment instrument is the National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Amendment Determination 2026 (No. 3).
This amendment made changes to the existing National Health (Commonwealth Price and Conditions for Commonwealth Payments for Supply of Pharmaceutical Benefits) Determination 2019 (PB 114 of 2019). The source does not specify which particular prices or conditions were altered.
Key dates
- Registered: 31 March 2026
- In force from: 31 March 2026
- Repealed: 18 August 2026
Key actions
- The full text of the amendment is available at https://www.legislation.gov.au/F2026L00406 - this is where specific pricing or supply condition changes under Schedule 1 are detailed.
- This determination was repealed on 18 August 2026. The Federal Register of Legislation is the place to check for any successor instrument that replaced it after that date.
This is a plain-English summary for information only, not legal or compliance advice. Always check the official source or consult a qualified professional.